TY - JOUR A1 - Morgner, Frank A1 - Stufler, Stefan A1 - Geissler, Daniel A1 - Medintz, Igor L. A1 - Algar, W. Russ A1 - Susumu, Kimihiro A1 - Stewart, Michael H. A1 - Blanco-Canosa, Juan B. A1 - Dawson, Philip E. A1 - Hildebrandt, Niko T1 - Terbium to quantum dot FRET Bioconjugates for clinical diagnostics influence of human plasma on optical and assembly properties JF - Sensors N2 - Forster resonance energy transfer (FRET) from luminescent terbium complexes (LTC) as donors to semiconductor quantum dots (QDs) as acceptors allows extraordinary large FRET efficiencies due to the long Forster distances afforded. Moreover, time-gated detection permits an efficient suppression of autofluorescent background leading to sub-picomolar detection limits even within multiplexed detection formats. These characteristics make FRET-systems with LTC and QDs excellent candidates for clinical diagnostics. So far, such proofs of principle for highly sensitive multiplexed biosensing have only been performed under optimized buffer conditions and interactions between real-life clinical media such as human serum or plasma and LTC-QD-FRET-systems have not yet been taken into account. Here we present an extensive spectroscopic analysis of absorption, excitation and emission spectra along with the luminescence decay times of both the single components as well as the assembled FRET-systems in TRIS-buffer, TRIS-buffer with 2% bovine serum albumin, and fresh human plasma. Moreover, we evaluated homogeneous LTC-QD FRET assays in QD conjugates assembled with either the well-known, specific biotin-streptavidin biological interaction or, alternatively, the metal-affinity coordination of histidine to zinc. In the case of conjugates assembled with biotin-streptavidin no significant interference with the optical and binding properties occurs whereas the histidine-zinc system appears to be affected by human plasma. KW - FRET KW - quantum dots KW - terbium KW - luminescence lifetime KW - blood KW - plasma KW - clinical diagnostics KW - biotin KW - streptavidin KW - histidin KW - immunoassay Y1 - 2011 U6 - https://doi.org/10.3390/s111009667 SN - 1424-8220 VL - 11 IS - 10 SP - 9667 EP - 9684 PB - MDPI CY - Basel ER - TY - JOUR A1 - Morgner, Frank A1 - Bennemann, Mark A1 - Cywiński, Piotr J. A1 - Kollosche, Matthias A1 - Górski, Krzysztof A1 - Pietraszkiewicz, Marek A1 - Geßner, André A1 - Löhmannsröben, Hans-Gerd T1 - Elastic FRET sensors for contactless pressure measurement JF - RSC Advances : an international journal to further the chemical sciences N2 - Contactless pressure monitoring based on Forster resonance energy transfer between donor/acceptor pairs immobilized within elastomers is demonstrated. The donor/acceptor energy transfer is employed by dispersing terbium(III) tris[(2-hydroxybenzoyl)-2-aminoethyl] amine complex (LLC, donor) and CdSe/ZnS quantum dots (QD655, acceptor) in styrene-ethylene/buthylene-styrene (SEBS) and poly(dimethylsiloxane) (PDMS). The continuous monitoring of QD luminescence showed a reversible intensity change as the pressure signal is alternated between two stable states indicating a pressure sensitivity of 6350 cps kPa(-1). Time-resolved measurements show the pressure impact on the FRET signal due to an increase of decay time (270 ms up to 420 ms) for the donor signal and parallel drop of decay time (170 mu s to 155 mu s) for the acceptor signal as the net pressure applied. The LLC/QD655 sensors enable a contactless readout as well as space resolved monitoring to enable miniaturization towards smaller integrated stretchable opto-electronics. Elastic FRET sensors can potentially lead to developing profitable analysis systems capable to outdo conventional wired electronic systems (inductive, capacitive, ultrasonic and photoelectric sensors) especially for point-of-care diagnostics, biological monitoring required for wearable electronics. Y1 - 2017 U6 - https://doi.org/10.1039/c7ra06379b SN - 2046-2069 VL - 7 SP - 50578 EP - 50583 PB - RSC Publishing CY - Cambridge ER - TY - JOUR A1 - Morgner, Frank A1 - Lecointre, Alexandre A1 - Charbonniere, Loic J. A1 - Löhmannsröben, Hans-Gerd T1 - Detecting free hemoglobin in blood plasma and serum with luminescent terbium complexes JF - Physical chemistry, chemical physics : a journal of European Chemical Societies N2 - Hemolysis, the rupturing of red blood cells, can result from numerous medical conditions (in vivo) or occur after collecting blood specimen or extracting plasma and serum out of whole blood (in vitro). In clinical laboratory practice, hemolysis can be a serious problem due to its potential to bias detection of various analytes or biomarkers. Here we present the first "mix-and-measure' method to assess the degree of hemolysis in biosamples using luminescence spectroscopy. Luminescent terbium complexes (LTC) were studied in the presence of free hemoglobin (Hb) as indicators for hemolysis in TRIS-buffer, and in fresh human plasma with absorption, excitation and emission measurements. Our findings indicate dynamic as well as resonance energy transfer (FRET) between the LTC and the porphyrin ligand of hemoglobin. This transfer leads to a decrease in luminescence intensity and decay time even at nanomolar hemoglobin concentrations either in buffer or plasma. Luminescent terbium complexes are very sensitive to free hemoglobin in buffer and blood plasma. Due to the instant change in luminescence properties of the LTC in presence of Hb it is possible to access the concentration of hemoglobin via spectroscopic methods without incubation time or further treatment of the sample thus enabling a rapid and sensitive detection of hemolysis in clinical diagnostics. Y1 - 2015 U6 - https://doi.org/10.1039/c4cp04206a SN - 1463-9076 SN - 1463-9084 VL - 17 IS - 3 SP - 1740 EP - 1745 PB - Royal Society of Chemistry CY - Cambridge ER -